Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73051 - 73075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	SPP1	6696	downregulated	Silicon Dioxide results in decreased expression of SPP1 mRNA	4q22.1	A24203
Silicon dioxide	Approved	SPP2	6694	upregulated	Silicon Dioxide analog results in increased expression of SPP2 mRNA	2q37.1	A24195
Silicon dioxide	Approved	SPRR2B	6701	upregulated	Silicon Dioxide results in increased expression of SPRR2B mRNA	1q21.3	A24196
Silicon dioxide	Approved	SPRR2C	6702	upregulated	Silicon Dioxide results in increased expression of SPRR2C mRNA	1q21.3	A24196
Silicon dioxide	Approved	SPRY1	10252	downregulated	Silicon Dioxide analog results in decreased expression of SPRY1 mRNA	4q28.1	A24195
Silicon dioxide	Approved	SPRY4	81848	upregulated	Silicon Dioxide results in increased expression of SPRY4 mRNA	5q31.3	A24197 A24196
Silicon dioxide	Approved	SPTB	6710	downregulated	Silicon Dioxide analog results in decreased expression of SPTB mRNA	14q23.3	A24195
Silicon dioxide	Approved	SPTBN1	6711	downregulated	Silicon Dioxide results in decreased expression of SPTBN1 mRNA	2p16.2	A24196
Silicon dioxide	Approved	SPTBN4	57731	downregulated	Silicon Dioxide analog results in decreased expression of SPTBN4 mRNA	19q13.13	A24195
Silicon dioxide	Approved	SPTLC3	55304	downregulated	Silicon Dioxide analog results in decreased expression of SPTLC3 mRNA	20p12.1	A24195
Silicon dioxide	Approved	SPTSSA	171546	downregulated	Silicon Dioxide analog results in decreased expression of SPTSSA mRNA	14q13.1	A24195
Silicon dioxide	Approved	SPX	80763	downregulated	Silicon Dioxide analog results in decreased expression of SPX mRNA	12p12.1	A24195
Silicon dioxide	Approved	SPX	80763	upregulated	Silicon Dioxide analog results in increased expression of SPX mRNA	12p12.1	A24194
Silicon dioxide	Approved	SQSTM1	8878	upregulated	Silicon Dioxide analog results in increased expression of SQSTM1 mRNA	5q35.3	A24194 A24195
Silicon dioxide	Approved	SQSTM1	8878	upregulated	Silicon Dioxide results in increased expression of SQSTM1 mRNA	5q35.3	A24196
Silicon dioxide	Approved	SRCAP	10847	upregulated	Silicon Dioxide results in increased expression of SRCAP mRNA	16p11.2	A24196
Silicon dioxide	Approved	SRCIN1	80725	downregulated	Silicon Dioxide analog results in decreased expression of SRCIN1 mRNA	17q12	A24194 A24195
Silicon dioxide	Approved	SRD5A1	6715	downregulated	Silicon Dioxide results in decreased expression of SRD5A1 mRNA	5p15.31	A24196
Silicon dioxide	Approved	SRD5A3	79644	downregulated	Silicon Dioxide results in decreased expression of SRD5A3 mRNA	4q12	A24196
Silicon dioxide	Approved	SREBF2	6721	downregulated	Silicon Dioxide analog results in decreased expression of SREBF2 mRNA	22q13.2	A24195
Silicon dioxide	Approved	SRGAP3	9901	downregulated	Silicon Dioxide analog results in decreased expression of SRGAP3 mRNA	3p25.3	A24195
Silicon dioxide	Approved	SRM	6723	upregulated	Silicon Dioxide analog results in increased expression of SRM mRNA	1p36.22	A24195
Silicon dioxide	Approved	SRPX2	27286	downregulated	Silicon Dioxide analog results in decreased expression of SRPX2 mRNA	Xq22.1	A24195
Silicon dioxide	Approved	SRRM3	222183	downregulated	Silicon Dioxide analog results in decreased expression of SRRM3 mRNA	7q11.23	A24195
Silicon dioxide	Approved	SRSF11	9295	upregulated	Silicon Dioxide results in increased expression of SRSF11 mRNA	1p31.1	A24196

Displaying entries 73051 - 73075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability